Wolpert C, Kuschyk J, Aramin N, Spehl S, Streitner F, Süselbeck T, Schumacher B, Haase K K, Schimpf R, Borggrefe M
1st Department of Medicine-Cardiology, University Hospital of Mannheim, Faculty of Clinical Medicine of the University of Heidelberg, Mannheim, Germany.
Heart. 2004 Jun;90(6):667-71. doi: 10.1136/hrt.2003.019042.
To assess the incidence and electrophysiological characteristics of spontaneous ventricular tachyarrhythmias after implantable cardioverter-defibrillator (ICD) implantation for primary prevention.
Prospective observational study.
41 consecutive patients, who fulfilled MADIT (multicenter automatic defibrillator implantation trial) I criteria, except for suppressibility by procainamide, and who received a prophylactic ICD.
Subpectoral implantation of an ICD.
Incidence of ventricular tachyarrhythmias and their electrophysiological characteristics with respect to timing of the arrhythmia, tachyarrhythmia cycle length, mode of termination, and clinical relevance.
During a mean (SD) follow up of 30 (21) months 18 of 41 (43.9%) patients experienced 142 appropriate ICD treatments. The mean (SD) time to first event was 9.6 (15.1) months. One patient had ventricular fibrillation (VF), 12 patients ventricular tachycardia (VT), and five both VT and VF. The mean (SD) cycle length of monomorphic VT was 306 (42) ms. Of 142 episodes, 117 (82.3%) were terminated by antitachycardia pacing and another 25 (17.6%) by ICD discharges. Cumulative survival of hypothetical death, defined as treated VT with a cycle length < 260 ms or VF, was 83.2% after one year and 78.4% after two years.
Patients with a left ventricular ejection fraction < 35%, a history of myocardial infarction, non-sustained VT, and inducible VT/VF are at high risk of VT/VF early after implantation. Therefore, implantation of a tiered treatment defibrillator seems to be justified.
评估植入式心脏复律除颤器(ICD)植入用于一级预防后自发性室性快速性心律失常的发生率及电生理特征。
前瞻性观察性研究。
41例连续患者,符合多中心自动除颤器植入试验(MADIT)I标准,但可被普鲁卡因胺抑制者除外,且接受了预防性ICD植入。
在胸大肌下植入ICD。
室性快速性心律失常的发生率及其与心律失常发生时间、快速性心律失常周期长度、终止方式及临床相关性相关的电生理特征。
在平均(标准差)30(21)个月的随访期间,41例患者中有18例(43.9%)经历了142次适当的ICD治疗。首次事件的平均(标准差)时间为9.6(15.1)个月。1例患者发生心室颤动(VF),12例患者发生室性心动过速(VT),5例患者同时发生VT和VF。单形性VT的平均(标准差)周期长度为306(42)ms。在142次发作中,117次(82.3%)通过抗心动过速起搏终止,另外25次(17.6%)通过ICD放电终止。定义为周期长度<260 ms的治疗性VT或VF的假设性死亡的累积生存率在1年后为83.2%,2年后为78.4%。
左心室射血分数<35%、有心肌梗死病史、非持续性VT以及可诱发VT/VF的患者在植入后早期发生VT/VF的风险很高。因此,植入分层治疗除颤器似乎是合理的。